CeraFlex PFO Closure System PMCF Study | MicrobiomeTrials← Back to trialsNCT06120270
CeraFlex PFO Closure System PMCF Study
RecruitingOBSERVATIONAL
Trial Details
Start: 2023-11-03Est. Completion: 2026-12
Enrollment target: 180 participants Locations- Kardiologisch-Angiologische Praxis - Herzzentrum Bremen, Bremen, Germany
- Heart Center Dresden, Dresden, Germany
- Hospital Fürth, Fürth, Germany
- Kath. Marienkrankenhaus gGmbH, Hamburg, Germany
- Universitätsklinikum Hamburg-Eppendorf (UKE), Hamburg, Germany
- German Heart Center Leipzig, Leipzig, Germany
- Klinikum St. Georg gGmbH Leipzig, Leipzig, Germany
- German Heart Center Munich, Munich, Germany
- Herzzentrum Trier, Trier, Germany
- University clinic Tübingen, Tübingen, Germany
- Chonnam National University Hospital, Gwangju, Gwangju, South Korea
- Yeungnam University Medical Center, Daegu, South Korea
- ASAN Medical Center, Seoul, South Korea
- Samsung Medical Center, Seoul, South Korea
- Catholic University of Korea St. Vincent's Hospital, Suwon, South Korea
Other microbiome trials you might be interested in
MigrainePatent Foramen OvalePFO - Patent Foramen Ovale
Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occlud…
Phoenix, United StatesCompleted Aug 15, 2024
Migraine DiseasePatent Foramen Ovale
Migraine is a common and often disabling condition, but its exact causes are not fully understood. Some people with migr…
New York, United StatesEst. completion Dec 2027
Contact